Sentences with phrase «groups at baseline»

The quality of each study was evaluated independently by MS and SJM according to the following eight validity criteria, which were adapted from the Consolidated Standards of Reporting Trials (CONSORT) guidelines [14,15] and Delphi criteria list [16]: randomization; allocation concealment; blinding of outcome assessments; comparability of groups at baseline; withdrawals; handling of dropouts in analyses; use of intention - to - treat analysis; and multiple follow - up assessments.

The main limitations for the studies were not comparing groups at baseline [4,20,22,23]; not reporting the use of intention - to - treat analyses or handling of missing data [4,6,18,21]; and not using follow - up assessments [4,6,18,20,22,24].

Limitations include significant differences between the HFA and control groups at baseline (generally indicating the HV group was at higher risk, and addressed through statistical control), small sample size, and lack of information on service that may have been received by the control group families.

Limitations include the small sample size, differences between the two groups at baseline, and the large amounts of missing data.

No significant differences were found between groups at baseline or at 3 months.

Limitations include nonrandomization of participants, small sample size, and significant differences between the two groups at baseline.

Limitations include the differences between the two groups at baseline, differences between the intervention delivered in the two groups (the open - group format did not include the child component of the program, while the closed - group format did), and the high attrition rates in the open - group sample.

Families who chose to participate in the program were compared to nonparticipating families; there were significant differences between the groups at baseline.

Table 1 illustrates no significant demographic differences across groups at baseline.

Although there were no differences in child intelligence across groups at baseline, children in the DC group showed a decline, particularly if their mothers had a subsequent depressive episode.

Table I outlines the number of schools, classes and teachers assigned to intervention and control groups at the baseline.

Limitations include non-randomization of participants and differences between the two groups at baseline.

Limitations include small sample size, issues with the randomization of participants that resulted in differences between the groups at baseline, reliance on self - reported measures as reduction in symptoms were significant for adolescent reports but not for parent report, and generalizability due to the primarily female participant gender.

Covariates were included if they differed statistically between the intervention and comparison groups at baseline or if inclusion in an analytic model caused point estimates of effect size to vary by more than 10 %.

There were no significant differences between the quality improvement and usual care groups at baseline.

Because all other measures were comparable between groups at baseline, we infer that CPSS was as well.

Initial analyses examined potential differences in participant characteristics and demographics across intervention groups at baseline by using independent samples t tests for continuous variables and χ2 analyses for categorical variables.

The RCT study design with an active comparison group (controlling for positive adult instructor and group activity) and comparable groups at baseline provides a high level of confidence that the improvements seen in the MBSR arm are due specifically to the mindfulness aspects of the intervention, as opposed to baseline differences and / or other nonspecific intervention effects.

When comparing HT and MBSR groups at baseline, χ2 tests revealed no significant differences in gender (P =.99), ethnicity (P =.32), age (P =.45), nor any study variables of interest (P =.10 — .99).

There were no substantive differences between study groups at baseline; 8506 women were randomized into the estrogen plus progestin group and 8102 into the placebo group (Table 1a).

Despite the worse status of the intervention group at baseline, the study showed a trend for improvement in quality of life at three months and clinically meaningful improvement at four months.

The effectiveness of the randomisation procedure was validated by comparing the intervention and control group at baseline using a series of χ2 and t - tests.

Table 1 gives the characteristics by group at baseline and at 6 months.

Expected cognitive deficits were found in the depressed compared to the control group at baseline although only a few domains (verbal learning, memory and executive functioning) were related to depressive severity.

The model was expanded to included analysis of covariance within the structural equation modelling framework in order to correct for measurement error and adjusting for the imbalance in scores across the intervention and control group at the baseline.

Not exact matches

At the end of the year, after adjusting for the baseline prevalence of being overweight, the authors found a 31 % decrease in the risk of obesity in the intervention group.

A larger study, with randomization to intervention and control groups might help define whether changes were attributable to the intervention, to differences at baseline, or to other influences.

This further supports the value of massage for colicky infants since the treatment group made significant gain beyond the control group even though the control group was better off at baseline.

Interestingly, at baseline, the mean of cry duration (4.96 hours in the massage and three hours in rocking groups), sleep duration (9.29 hours in the massage and 12.24 hours in the rock groups), and infant colic severity were significantly different.

The groups of women appeared to be comparable at baseline: «(T) here was no evidence of pretreatment covariate imbalance among women assigned to a treatment arm».

Groups appeared balanced at baseline.

The 2 groups of women appeared to have similar baseline characteristics: «Dyads in the intervention and control group did not differ with regard to maternal age, education, type of medical coverage, week at which prenatal care was initiated, infant gestational age at birth, race, or rate of vaginal delivery».

Groups appeared similar at baseline.

National baseline prevalence reported in paper was similar to the control group rates; UNICEF quoted higher rates - 53 % exclusive breastfeeding at 0 - 3 months

One suggestion broached by the New York State Association of School Business Officials and other Albany - based groups is to set the baseline cap at a flat 2 percent, getting rid of the inflation rate as a factor.

it may be alarmingly high and we need to get at least a baseline level,» MRB Engineering Group consultant David Lukas wrote in a January 15 email to the health department's Vickerson.

On reanalysing data from the group's past studies, such as on pain sensitivity to hot water, the researchers found that mice tested by men showed lower baseline pain sensitivity than mice tested by women.The work indirectly demonstrates potential effects on nearly any kind of medical research, says Joseph Garner, who studies mouse behavior and well - being at Stanford University in California.

Migraine days were significantly reduced within all three groups from baseline to post-treatment; the effect continued in the CSMT and placebo groups at all follow - up time points, whereas the control group returned to baseline.

At baseline, study patients had an average Clinician - Administered PTSD Scale (CAPS) score of 79, but after MDMA - assisted therapy, CAPS scores dropped to 23.4 in the 13 - person MDMA group, whereas an eight - person placebo group averaged a score of 60.

Clinical assessments were obtained for both groups at each time point, as well as at the baseline before the football season.

The combination of being able to identify people online for a baseline survey, then reach them going door - to - door, and finally resurvey those same people online at a later point has dramatically reduced the canvassers» need to knock on doors by one or two orders of magnitude, and makes comparison groups much more feasible.

A comparison of the number of symptoms cited at baseline showed no significant difference between the two age groups (average number of symptoms: 3.4 in the younger group and 2.5 in the older group, p < 0.111).

At week 54, BASDAI improved significantly from baseline in both treatment groups (CT - P13: from 6.74 to 3.78 and INX: from 6.57 to 3.70) and this improvement was similar between groups (difference of means -0.29; CI of the difference -0.91 to 0.32).

By studying the athletes at baseline before the season began, Bartha, and PhD candidate Amy Schranz were able to compare the subjects to themselves instead of to a control group, allowing them to see very subtle changes.

In addition, a 50 % improvement of the baseline BASDAI (BASDAI50) was achieved in 44.3 % for CT - P13 and 46.3 % for INX at week 54; the BASDAI50 response rate was comparable between the two groups (p = 0.7737).

Using functional magnetic resonance imaging (fMRI), an imaging technique that measures brain activity, researchers examined all three groups at the beginning (baseline), middle, and end of the study while participants performed computer - based speed tasks in the scanner.

Dr Simon Stanworth, at NHSBT / Oxford University Hospitals NHS Trust, indicated the importance of the study as a baseline recording of practice: «This study tells us about the challenges of early delivery and administration of blood patients to a group of patients with life - threatening injuries.

The study group comprised 72,916 female registered nurses ages 41 - 58 years in 2005, free of diabetes, stroke, and pregnancy at the baseline.

At week 4, 47.1 percent of participants treated with varenicline reduced the number of cigarettes smoked per day compared with baseline by 50 percent or more or abstained completely compared with 31.1 percent of participants treated with placebo; after 8 weeks, 26.3 percent participants in the varenicline group reduced smoking by 75 percent or more from baseline or abstained compared with 15.1 percent participants in the placebo group.

Using the findings of the TRIO study [2] as the basis for their recommendations, the Working Group recommends measuring serum PINP (procollagen type 1 N - terminal propeptide) and CTX (collagen type 1 C - terminal telopeptide) levels at baseline and after 3 months of initiating treatment.